Sajjad Vakili-Samiani

Sajjad Vakili-Samiani (MS, Hematology, Tabriz university of medical science, 2022) he took his comprehensive fields in Hematological malignancies target therapy with minor fields in Nanomedicine. His MSc thesis explored treating childhood Acute Lymphoblastic Leukemia (ALL) via selective targeting of WEE1 kinase as a treatment associated resistance factor. His current research focus on improvement of DNA damage based chemotheraputic agent's efficiency using specific immunoengineered and biocompatible nanoparticles. He is intrested in clinical research and clinical trial on ALL molecular target therapy to examine feasibility of his previous hypothesis.

Living in : Iran

Gender : MaleRace : Middle Eastern

0Followers 0Following

Academic Profile

Posts

Contact Information

-Email

SajjadVakili-SamianiApplyChance Link

Educations

Hematology And Blood TransfusionMaster'sTabriz University of Medical Sciences2022-07-19 Iran

Supervisor's name :Farhad Jadidi-Niaragh

Title :

Wee1 kinase gene silencing by siRNA carried by TAT-CCMD Nanoparticle complex, could eliminate Doxorubicin resistance in Acute lymphoblastic leukemia.

Work Experiences

Laboratory technician

at Tabriz university of medi

Start : 19-Oct-2021

End : 28-Feb-2022

Journal Publications

Publication Title :

Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticlesSecond author

Journal :

Journal of Drug Delivery Science and Technology

Link :

View Link

Publication Title :

The role of miRNA-424 and miR-631 in various cancers: Focusing on drug resistance and sensitivityCorresponding author

Journal :

Pathology Research and Practice

Link :

View Link

Publication Title :

Paediatric pre-B acute lymphoblastic leukaemia-derived exosomes regulate immune function in human T cellsCorresponding author